Contravisory Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.71M |
| 2 |
Kimberly-Clark
KMB
|
+$5.62M |
| 3 |
Republic Services
RSG
|
+$5.6M |
| 4 |
Procter & Gamble
PG
|
+$4.06M |
| 5 |
Darden Restaurants
DRI
|
+$3.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$4.87M |
| 2 |
HP
HPQ
|
+$4.75M |
| 3 |
Humana
HUM
|
+$4.26M |
| 4 |
Markel Group
MKL
|
+$4.11M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$4.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.53% |
| 2 | Consumer Staples | 11.11% |
| 3 | Industrials | 10.54% |
| 4 | Financials | 9.14% |
| 5 | Healthcare | 8.89% |
Similar funds
Contravisory Investment Management's Q2 2019 Portfolio in Review
As of Q2 2019, Contravisory Investment Management held 343 positions worth $259M, up 0.24% from $258M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Contravisory Investment Management withdrew a net $11M in Q2 2019, closing 71 positions and reducing 61 holdings. Its most notable exit was Elevance Health, an estimated $4.87M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Contravisory Investment Management opened a new position in AvalonBay Communities worth $3.9M.
- Contravisory Investment Management's largest Q2 2019 buy was AvalonBay Communities: 19,217 shares worth $3.9M.
- Contravisory Investment Management added most to Microsoft in Q2 2019, an estimated $5.71M increase.
- Contravisory Investment Management's biggest Q2 2019 reduction was Universal Health Services, cutting an estimated $588K.
- Contravisory Investment Management fully exited Elevance Health in Q2 2019, selling an estimated $4.87M.
- Contravisory Investment Management's ten largest holdings make up 27% of its $259M portfolio in Q2 2019.
- Contravisory Investment Management opened 40 new positions and closed 71 in Q2 2019.
- Contravisory Investment Management's portfolio value rose 0.24% quarter-over-quarter to $259M.
Based on Contravisory Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.